Similarly, anti-inflammatory, antioxidant and anti-ischemic properties have been described with GLP-1 receptor agonists.6668 Furthermore, given that adiposity plays a central role in the etiopathogenesis of cardio-reno-metabolic syndrome, GLP-1 receptor agonists would be of particular interest in this clinical context, since they have been shown to be protective at the renal, cardiovascular and metabolic levels, in addition to reducing appetite, weight loss and improved glycemic control.16 Finally, small clinical trials and observational studies are showing modest benefits at the glycemic level and on body weight, both in patients with end-stage renal disease and in renal transplant patients
Our friendly yet knowledgeable staff are here to help
Our team of integrative dietitians supports clients where they are, whether that includes using GLP-1 medications or not, with individualized nutrition guidance so body changes do not come at the expense of strength, energy, or health
To further support your weight loss journey, our IV Vitamin Nutrient Therapy drips help boost metabolism, improve energy levels, and support detoxification from within
The high heterogeneity observed for semaglutide further underscores the challenges of using genetic proxies for this drug